Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Alimentary Pharmacology & Therapeutics
|
April 1, 1990
The safety and efficacy of tripotassium dicitrato bismuthate (De-Nol) maintenance therapy in patients with duodenal ulceration
A A Dunk, U Prabhu, A Tobin, et al.
British Medical Journal (Clinical Research Ed.)
|
May 29, 1982
Diclofenac hepatitis
A A Dunk, R P Walt, W J Jenkins, et al.
Gut
|
May 13, 2005
An unusual cause of pyrexia
D C Howlett, M Segwagwe, N D P Marchbank, et al.
British Medical Journal (Clinical Research Ed.)
|
August 27, 1983
Precipitation of hepatic encephalopathy by propranolol in cirrhosis
D Tarver, R P Walt, A A Dunk, et al.
Alimentary Pharmacology & Therapeutics
|
February 1, 1990
The value of flumazenil in the reversal of midazolam-induced sedation for upper gastrointestinal endoscopy
A A Dunk, A C Norton, M Hudson, et al.
Annales De Genetique
|
March 1, 1978
A case of partial 9p monosomy with some unusual clinical features
F J Rutten, T W Hustinx, A A Dunk-Tillemans, et al.
Hepatology (Baltimore, Md.)
|
November 1, 1985
A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication
A S Lok, D M Novick, P Karayiannis, et al.
Alimentary Pharmacology & Therapeutics
|
August 1, 1987
Human lymphoblastoid interferon does not increase survival when added to mitozantrone in the treatment of hepatocellular carcinomas
M G Brook, A A Dunk, J A McDonald, et al.
Alimentary Pharmacology & Therapeutics
|
April 1, 1988
The effects of propranolol on hepatic encephalopathy in patients with cirrhosis and portal hypertension
A A Dunk, J Moore, A Symon, et al.
International Journal of Cancer
|
January 15, 1988
Hepatocellular carcinoma: clinical, aetiological and pathological features in British patients
A A Dunk, H Spiliadis, S Sherlock, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Alimentary Pharmacology & Therapeutics
|
April 1, 1990
The safety and efficacy of tripotassium dicitrato bismuthate (De-Nol) maintenance therapy in patients with duodenal ulceration
A A Dunk, U Prabhu, A Tobin, et al.
British Medical Journal (Clinical Research Ed.)
|
May 29, 1982
Diclofenac hepatitis
A A Dunk, R P Walt, W J Jenkins, et al.
Gut
|
May 13, 2005
An unusual cause of pyrexia
D C Howlett, M Segwagwe, N D P Marchbank, et al.
British Medical Journal (Clinical Research Ed.)
|
August 27, 1983
Precipitation of hepatic encephalopathy by propranolol in cirrhosis
D Tarver, R P Walt, A A Dunk, et al.
Alimentary Pharmacology & Therapeutics
|
February 1, 1990
The value of flumazenil in the reversal of midazolam-induced sedation for upper gastrointestinal endoscopy
A A Dunk, A C Norton, M Hudson, et al.
Annales De Genetique
|
March 1, 1978
A case of partial 9p monosomy with some unusual clinical features
F J Rutten, T W Hustinx, A A Dunk-Tillemans, et al.
Hepatology (Baltimore, Md.)
|
November 1, 1985
A randomized study of the effects of adenine arabinoside 5'-monophosphate (short or long courses) and lymphoblastoid interferon on hepatitis B virus replication
A S Lok, D M Novick, P Karayiannis, et al.
Alimentary Pharmacology & Therapeutics
|
August 1, 1987
Human lymphoblastoid interferon does not increase survival when added to mitozantrone in the treatment of hepatocellular carcinomas
M G Brook, A A Dunk, J A McDonald, et al.
Alimentary Pharmacology & Therapeutics
|
April 1, 1988
The effects of propranolol on hepatic encephalopathy in patients with cirrhosis and portal hypertension
A A Dunk, J Moore, A Symon, et al.
International Journal of Cancer
|
January 15, 1988
Hepatocellular carcinoma: clinical, aetiological and pathological features in British patients
A A Dunk, H Spiliadis, S Sherlock, et al.
Page
of 3